InQLab

InQLab operates as a startup studio rather than a traditional VC, which changes the whole shape of engagement for any healthcare founder evaluating it. Backed by Valorem and rooted in Bogota, the firm builds and invests in digital businesses targeting the Colombian market, with seed and Series A checks in the $250k to $1M range. The thesis is digital business building broadly defined; healthcare and digital health show up in the firm’s interest set, but the model is best suited to founders who either come into the studio’s company-building process at inception or are operating a Colombian digital health business that fits the studio’s thematic playbook. The fund’s stated AI focus is muted in the source data, which suggests this is a technology-enabled rather than AI-native investor, and founders should not lead with model architecture in the pitch. The right founder profile is a Colombian or LatAm-based operator with deep local market knowledge, building Spanish-language health software, payer or provider workflow tools, or tech-enabled services that benefit from a builder’s hands on operations, hiring, and go-to-market. The wrong profile is a US-based founder using Colombia as a cost center, a regulated medical device company needing clinical syndicate construction, or a high-burn growth-stage business; InQLab’s check size and studio orientation make those poor matches. Intro paths run through Bogota’s startup ecosystem, including Rockstart LatAm, Polymath Ventures, the Endeavor Colombia network, and Valorem-affiliated executives, all of whom touch InQLab’s deal flow. Direct application through the studio’s standard channels works for builders applying to be embedded as founders, but for outside companies seeking investment, a warm referral materially improves diligence speed. In the pitch, lead with the Colombian market dynamics that make your wedge defensible, the regulatory posture under the Ministry of Health and INVIMA where relevant, and an honest map of the EPS and IPS payer-provider landscape, because LatAm health investors expect founders to speak fluently about local plumbing. Be candid about cross-border ambition, which most LatAm health businesses ultimately need; InQLab is an early partner that benefits from Mexico, Chile, or Peru optionality but does not finance regional expansion alone. Caveats are important. Studios can look like investors but operate with different governance norms, sometimes including higher founder dilution at formation, board roles tied to studio resources, and shared services that are valuable early but can complicate hiring later. Read the studio agreement carefully and budget for a separate seed round with a non-studio lead within twelve to eighteen months. For the right founder, InQLab is a credible first capital partner; for the wrong one, the studio model creates friction that a clean angel or seed VC would not.